Home Search
cancer - search results
If you're not happy with the results, please do another search
Roche’s Tumor Mutational Burden Measuring Assay Capable Of Accurately Predicting Immunotherapy Efficacy
Tumor Mutational Burden Measuring Assay Predicts Immunotherapy
While immunotherapy has rapidly advanced clinical care in some cancers, many patients still don't see a benefit over...
Merck And Project Data Sphere Enter Strategic Collaboration, To Jointly Lead The Global Oncology...
Merck And Project Data Sphere Enter Strategic Collaboration
A leading science and technology company, Merck has now announced a strategic collaboration with Project Data Sphere...
Scientists Harness Fire Ant Venom To Treat Psoriasis
Scientists Harness Fire Ant Venom To Treat Psoriasis
Fire ants are such a pain. In addition to all the jolly eating, they are major pests...
GSK To Back Adaptimmune’s T-Cell Therapy Program
GSK To Back Adaptimmune’s T-Cell Therapy Program
GlaxoSmithKline has exercised its option under collaboration and license agreement signed in 2014 to exclusively license the right...
Biotecnika Times – Newsletter 11.09.2017
Govt Job @ UPSC | Junior Scientific Officer Post Vacant With Salary of Rs. 44,900/- p.m.
(Vacancy No. 17091701509) Two Junior Scientific Officer, National Centre...
Genetics Throws Light On Early “Vampires” (Pun Intended)
Genetics Throws Light On Early “Vampires” (Pun Intended)
Vampires have always been, and always will be a rage. These things somehow seem to ooze cool....
Gritstone Oncology Hauls $93M In Series B Funding
Gritstone Oncology Hauls $93M In Series B Funding
California-based cancer upstart, Gritstone Oncology, has announced successful completion of $92.7 million series B preferred stock financing.
The...
Scottish Biotech NuCana Expects To Raise $115M In A Nasdaq IPO
Scottish Biotech NuCana Expects To Raise $115M In A Nasdaq IPO
The UK-based biopharmaceutical firm, NuCana, anticipates hauling $115 million in a Nasdaq IPO to...
23andMe Raises $200M, Intends To Expand Genetic R&D Arm
23andMe Raises $200M, Intends To Expand Genetic R&D Arm
A new addition to the growing list of venture-backed unicorns that are raising IPO-sized rounds from...
Biotecnika Times – Newsletter 07.09.2017
Online Applications Open For JAM - 2018
IITs and IISc are institutions of national importance and are well known, the world over, for quality education...
Merck KGaA Considering Selling Its Global Consumer Health Business
German drug giant Merck KGaA is reportedly considering selling its $1-billion global consumer health business, including that in India, in a move that the...
The Good, The Bad And The Ugly Of Zika- Scientists Now Harness The Virus’s...
We have all seen the ugly side of the Zika virus- a harmful virus that can cause devastating brain damage in babies, little did...
Scientists Blast Away Tumour Cells Using Laser Directed Gold Nanoparticles
Imagine an actor whom you fancy loading up gold nanoparticles, directed by lasers, blasting off cancer cells- literally frying them into oblivion. Such a...
Indian-Origin Vas Narasimhan To Succeed As Novartis, Global CEO
Novartis AG Chief Executive Joe Jimenez is stepping down in January after leading the Swiss pharmaceutical giant through a tumultuous eight years marked by...
Are You Diagnosing Yourself Right ? Checking For Melanomas Can Be Tricky Business
Melanoma is the most dangerous form of skin cancer, these cancerous growths develop when unrepaired DNA damage to skin cells triggers mutations that lead...
